SBCM
SOPH icon

Silverberg Bernstein Capital Management’s SOPHiA GENETICS SOPH Stock Holding History

Silverberg Bernstein Capital Management’s Portfolio SOPH Stock Details SOPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$386K Buy
66,869
+14,899
+29% +$75.6K 0.15% 55
2026
Q1 		$257K Buy
51,970
+4,155
+9% +$20.2K 0.14% 59
2025
Q4 		$223K Buy
47,815
+1,100
+2% +$4.98K 0.13% 60
2025
Q3 		$222K Buy
46,715
+1,000
+2% +$3.44K 0.13% 60
2025
Q2 		$142K Buy
45,715
+11,040
+32% +$32.9K 0.1% 62
2025
Q1 		$115K Buy
34,675
+12,211
+54% +$42.9K 0.11% 58
2024
Q4 		$70.1K Buy
+22,464
New +$76.5K 0.06% 52

Other funds holding SOPH

BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
BPCE
Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
NS
NBC Securities Birmingham, Alabama $1.48B AUM 31.07% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Silverberg Bernstein Capital Management's SOPH Position: Q2 2026 in Review

Silverberg Bernstein Capital Management increased its SOPHiA GENETICS (SOPH) stake by 29% in Q2 2026, buying an estimated $75.6K and bringing the position to 66,869 shares worth $386K. The position accounts for 0.15% of the portfolio, ranked #55.

Silverberg Bernstein Capital Management first reported a position in SOPH in Q4 2024 and has held it in 7 quarters since. 9 funds tracked by Wall St. Rank hold SOPH as of Q2 2026.

  • Silverberg Bernstein Capital Management held 66,869 shares of SOPHiA GENETICS worth $386K as of Q2 2026.
  • Silverberg Bernstein Capital Management bought 14,899 SOPHiA GENETICS shares in Q2 2026, an estimated $75.6K.
  • SOPHiA GENETICS made up 0.15% of Silverberg Bernstein Capital Management's portfolio in Q2 2026, its #55 holding.
  • Silverberg Bernstein Capital Management first reported a position in SOPHiA GENETICS in Q4 2024 and has held it in 7 quarters since.
  • 9 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q2 2026.

Based on Silverberg Bernstein Capital Management's 13F filing for Q2 2026, filed 7 Jul 2026.